1
TITLE: Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study
AUTHORS: Mateos, Maria Victoria; San Miguel, Jesus; Cavo, Michele; Creixenti, Joan Blade; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre H.; Liberati, Anna Marina; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Pei, Huiling; Krevvata, Maria; Carson, Robin; Borgsten, Fredrik; Dimopoulos, Meletios A.; ...More
PUBLISHED: 2022, SOURCE: BLOOD, VOLUME: 140
INDEXED IN: WOS
2
TITLE: A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation
AUTHORS: Katja Weisela; Chantal Doyen; Meletios Dimopoulos; Adrian Yee; Juan J Jose Lahuerta; Amber Martin; Karin Travers; Eric Druyts; Kabirraaj Toor; Niels Abildgaard; Jin Lu; Jan Van Droogenbroeck; Catarina Geraldes; Mario Petrini; Laurent Voillat; Eric Voog; Thierry Facon;
PUBLISHED: 2017, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 58, ISSUE: 1
INDEXED IN: WOS
3
TITLE: Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial
AUTHORS: Cyrille Hulin; Andrew Belch; Chaim Shustik; Maria Teresa Petrucci; Ulrich Duehrsen; Jin Lu; Kevin Song; Philippe Rodon; Brigitte Pegourie; Laurent Garderet; Hannah Hunter; Isabelle Azais; Richard Eek; Heinz Gisslinger; Margaret Macro; Shaker Dakhil; Cristina Goncalves; Richard LeBlanc; Ken Romeril; Bruno Royer; Chantal Doyen; Xavier Leleu; Fritz Offner; Nicolas Leupin; Vanessa Houck; Guang Chen; Annette Ervin Haynes; Meletios A Dimopoulos; Thierry Facon; ...More
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 30
INDEXED IN: Scopus WOS